Do We Need a New Classification System for Aortic Dissection?

Original Title: DISSECT: A New Approach to Categorization of Aortic Dissection. Reference: M.D. Dabe, et al. Eur J Vasc Endovasac Surg 2013;46:175-90

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation – Argentina

Aortic dissection is a lethal disease, especially in its first stages. The current classification systems (DeBakey 1965 and Stanford 1970) are widely used but provide little information, failing to explore all clinical and anatomical aortic features.

The new classification offers a global perspective through different complement diagnostic techniques (TEE, CT, and MRI) to assess the aorta and would help define the best strategy, not just to manage the acute, but to direct the whole course of treatment.

This new classification (DISSECT) uses a fast and simple mnemonic technique of 6 variables: Duration, Intimal tear, Size of aorta, Segmental Extent of involvement, Clinical complication and Thrombosis of false lumen. Duration is classified into acute, subacute and chronic, according to symptom onset (˂2 weeks, 2 weeks to 3 months and >3 months). It is directly associated to prognosis and treatment.

With the new diagnostic technique, we can locate the intimal tear and, as opposed to the traditional classifications, we can locate it in the ascending aorta, the aortic arch, the descending aorta, the abdominal aorta or an unknown location.

These techniques also enables us to better assess aortic diameter in every compromised segment and the extent in each segment, defined by length.

Complications are assessed through the presence of pain, incontrollable hypertension, aortic valve compromise, tamponade, rapture, bad perfusion caused by static or dynamic compromise (stroke, paraplegia, coronary, mesenteric, renal, visceral and/or limbs), proximal or distal progression, rapid growth (>10 mm) of false lumen or aortic diameter.
False lumen thrombosis may be partial, total or there may be patent flow in the different segments of the aorta. The presence of flow in the false lumen has been associated to late death.

Conclusion
This classification not only provides all the anatomical characteristics, it also provides the clinical characteristics, facilitating management with medical, surgical and endovascular treatment of aortic dissection.

Editorial Comment
This classification does not replace the conventional classifications that have been very useful; it only provides more dynamic information about the anatomical and clinical characteristics of aortic dissection. It also expedites assessment both in acute and in evolution, to help direct the course of therapy, be it medical management, open surgical repair or, the most recent alternative, endovascular treatment.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...